Atrial arrhythmias, including atrial fibrillation, in the setting of congenital heart disease (CHD) are epidemiologically and mechanistically different from those encountered in the general population. These arrhythmias occur at younger ages in patients with CHD, and are frequently
degenerative and progressive. The epidemiology, incidence, and prevalence of the spectrum of atrial arrhythmias, including atrial fibrillation, vary according to the specific CHD type, prior treatment, and residual and ongoing structural and functional sequelae. The combined impact of incisional
scars, abnormal hemodynamics, atrial chamber dilatation, and increases in atrial wall thickness and distribution of fibrosis results in a highly dynamic and continuously changing atrial substrate that is highly predisposed to arrhythmias. Given the multiple substrates, individualized therapeutic
plans can include pharmacologic therapy, catheter-based ablation, and surgical therapies performed concomitantly with primary surgical intervention for hemodynamically significant sequelae of CHD. Advanced imaging with CT or MRI can provide valuable information for decision making and procedural
planning. Application of novel therapeutic technologies and pharmacologic agents necessitates special considerations when applied to the CHD population and requires greater study in specific subsets of CHD patients.
No References for this article.
No Supplementary Data.
No Article Media
congenital heart disease
Document Type: Research Article
Publication date: May 1, 2018
More about this publication?
Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites